Chengda Pharmaceuticals Co (SZSE:301201) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301201 Chengda Pharmaceuticals Co Ltd SZSE:301201
75 GF Score
Price ¥37.94
GF Value ¥30.45
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Chengda Pharmaceuticals Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SZSE:301201 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chengda Pharmaceuticals Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengda Pharmaceuticals Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengda Pharmaceuticals Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Chengda Pharmaceuticals Co's Short Interest falls into.


SZSE:301201
75GF Score
Chengda Pharmaceuticals Co Ltd SZSE:301201
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chengda Pharmaceuticals Co (SZSE:301201) Overvalued in 2026?

Based on GuruFocus' analysis, Chengda Pharmaceuticals Co stock appears to be overvalued. The current stock price of ¥37.94 is trading 24.6% above its estimated GF Value™ of ¥30.45. GuruFocus considers Chengda Pharmaceuticals Co to be Modestly Overvalued.

Key valuation signals for SZSE:301201:

  • Short Interest:
  • GF Value™: ¥30.45 vs. price of ¥37.94 (24.6% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the SZSE:301201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chengda Pharmaceuticals Co Business Description

Address 36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100
Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.
75GF Score

Get the complete analysis for SZSE:301201

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥37.94
Price
¥30.45
GF Value